The development space of the off-campus market is vast, and pharmaceutical companies are laying out multi-channel

【Pharmaceutical Network Market Analysis】With the in-depth advancement of the collection policy, coupled with the impact of the epidemic on the hospital market, the outflow of prescriptions is accelerating, the original market pattern and commercial industry chain of the existing pharmaceutical industry have gradually been broken, and the market outside the hospital is becoming a new position
for pharmaceutical companies to compete.

It is understood that the off-hospital market includes a wide range of online and offline (retail pharmacies and private institutions (including private hospitals, private clinics and most village clinics contracted by village doctors, etc.
).


Under the background of further deepening medical reform and the more concentrated drug structure in hospitals, for many enterprises, actively exploring the off-campus market has become an inevitable trend
.

The author understands that at present, Pfizer, AstraZeneca, Bayer and other foreign-funded large pharmaceutical companies have already begun to set up special marketing teams to specialize in the outflow
of prescriptions in the grass-roots market.

For example, after the third batch of Pfizer collected and dropped the target, it has already done a re-analysis of the relevant strategy, and also made a strategy of "one product and two gauge three dosage forms" to help hospitals establish a rational drug use catalog
.

As early as July 9, 2019, Bayer reached a strategic cooperation intention with the pharmacist gang, and the two sides will give full play to their respective advantages in the fields of medicine and health and the Internet, build a one-stop operation platform from enterprise to terminal sales, and jointly create a new ecosystem of real-time interaction, openness and reachability, focusing on the service
of "sinking market".

In addition to multinational pharmaceutical companies, domestic pharmaceutical companies have also taken positive actions
against the blue ocean of the off-campus market.

In early August last year, Yuanxin Technology announced the completion of more than 1.
5 billion Series F financing
.

After this round of financing, Yuanxin Technology Group will further expand the patient's out-of-hospital service network and customize the post-diagnosis course management system
for multi-disease patients.

Subsequently, Jointown also signed a strategic cooperation agreement
with Tianfang Pharmaceutical.

It is understood that through this cooperation, Tianfang Pharmaceutical can obtain its perfect network and distribution service support, market maintenance, information value-added services and cooperation in
collecting related varieties.

Kyushu General Rules can take this opportunity to cooperate and extensively carry out cooperation in raw and auxiliary materials business, general sales and self-operation
.

It is worth noting that in a large number of enterprises that have opened up the market outside the hospital, it is clear that the use of digital means has also become a trend
.

It is reported that in April this year, Yaodou.
com signed a strategic cooperation agreement with Shenzhen Xingyin Pharmaceutical Co.
, Ltd.
in Beijing to cooperate
on the landing terminal of advantageous family standing drugs such as Xingyin Pharma Maizhiling tablets.

In addition, Gilead Science has also announced a strategic cooperation
with JD Health in the field of digital medical and health ecology.

The two sides will deeply explore the innovative practice of "Internet + medical health", jointly provide more professional, safe and convenient "one-stop" disease management solutions for patients with chronic infectious diseases, and accelerate the prevention
and control of infectious diseases such as HIV and chronic viral hepatitis.

Analysts believe that in the market outside the hospital, the network platform enterprises hold the advantages of capital and traffic, while the head batch zero integration commercial company holds a wealth of new special drug resources in its left hand and drags the advantages
of channels inside and outside the hospital with its right hand.

Under this pressure, it is expected that in the future, traditional pharmacies and pharmaceutical companies will not be willing to show weakness and accelerate the use of Internet platforms and digital technologies to seek transformation
.

In general, the innovation of policies is the main reason
for creating more opportunities for diversified sales outside the hospital.

In the future, with the continuous implementation of medical reform measures such as medical insurance cost control, centralized volume procurement, zero plus of drugs in hospitals, and prescription outflow, more and more pharmaceutical enterprises, traditional retail chain pharmacies and "Internet + medicine" enterprises will take the out-of-hospital market as a new direction
for extension and expansion.

Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.